Across the three treatment groups (dulaglutide 1.5 mg, dulaglutide 0.75 mg, and placebo), there were no cases of diabetic ketoacidosis or amputations, and hypotensive episodes/syncope occurred in 0%, 1% and 1%, genital infections in 0%, 0% and 1%, fractures in 1%, 1% and 1%, and gastrointestinal events in 32%, 21% and 17% of patients, respectively [31]
The medication is provided through licensed U.S
Int Orthop
In some cases, more significant side effects could occur, so its essential to monitor ones health and report any concerns to a healthcare provider
The optimal dosing schedule will vary depending on the desired therapeutic outcome and size of the subject
It induces adipogenic effects, leading to early weight gain that stabilizes over time, without the organomegaly associated with GH treatment